Aug 22 |
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
|
Aug 22 |
The FDA Approved a New Covid Vaccine. Should You Get It?
|
Aug 22 |
FDA Approves Updated Covid-19 Shots. Wall Street Isn’t Upbeat About Sales for Pfizer and Moderna.
|
Aug 22 |
Updated COVID shots from Pfizer, Moderna cleared by FDA
|
Aug 22 |
Moderna to Host Investor Event - R&D Day and Business Updates
|
Aug 21 |
Covid-19: vaccine pricing varies wildly by country and company
|
Aug 21 |
Myocarditis risks from Covid-19 vaccines are still less than the risks from Covid-19
|
Aug 20 |
Top 20 biopharmas’ market cap up 4.3% in Q2 2024 as GLP-1 drug innovators hold top spots
|
Aug 19 |
Shareholders have faith in loss-making Moderna (NASDAQ:MRNA) as stock climbs 6.8% in past week, taking five-year gain to 480%
|
Aug 19 |
Pfizer (PFE), BioNTech COVID-Flu Combo Shot Study Falters
|